NCR2 and neoplasm: Activating cytotoxicity receptors (NCRs), NKp46 (NCR1, CD335), NKp44 (NCR2, CD336), NKp30 (NCR3, CD337), contain immunoglobulin-like domains binding to tumor antigens, viral proteins, and some bacterial components (19).